An investigation for investors in Pulse Biosciences Inc (NASDAQ:PLSE) shares over potential securities laws violations by Pulse Biosciences Inc was announced.

San Diego, CA -- (SBWire) -- 09/25/2017 --An investigation on behalf of investors of Pulse Biosciences Inc (NASDAQ:PLSE) shares over potential securities laws violations by Pulse Biosciences Inc was announced.

Investors who purchased shares of Pulse Biosciences Inc (NASDAQ:PLSE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Pulse Biosciences Inc (NASDAQ:PLSE) concerning whether certain statements by Pulse Biosciences Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On September 11, 2017, Pulse Biosciences Inc disclosed "that it has withdrawn its initial application to the United States Food and Drug Administration (FDA) for 510(k) clearance of its PulseTxTM System." Pulse Biosciences Inc further disclosed that the "voluntary withdrawal on September 8, 2017, was the result of the FDA's appropriate request for additional data that could not be provided within the Agency's 90-day review period that would have otherwise ended on September 10, 2017."

Those who purchased shares of Pulse Biosciences Inc (NASDAQ:PLSE) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com